1 Min Read
April 3 (Reuters) - Immunicum AB:
* (PUBL) PROVIDES UPDATE ON ILIXADENCEL CLINICAL DEVELOPMENT PROGRAM
* SAYS PROCEEDS ACCORDING TO PLAN WITH ONGOING CLINICAL TRIALS FOR ILIXADENCEL Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.